Curaleaf Holdings, Inc. (TSX:CURA)
Canada
· Delayed Price · Currency is CAD Curaleaf Holdings Statistics
Total Valuation
TSX:CURA has a market cap or net worth of CAD 863.66 million. The enterprise value is 2.43 billion.
| Market Cap | 863.66M |
| Enterprise Value | 2.43B |
Important Dates
The next estimated earnings date is Thursday, August 7, 2025.
| Earnings Date | Aug 7, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:CURA has 757.60 million shares outstanding. The number of shares has increased by 1.97% in one year.
| Current Share Class | 663.63M |
| Shares Outstanding | 757.60M |
| Shares Change (YoY) | +1.97% |
| Shares Change (QoQ) | +0.15% |
| Owned by Insiders (%) | 18.78% |
| Owned by Institutions (%) | 3.32% |
| Float | 609.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.46 |
| PB Ratio | 0.62 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 9.60 |
| P/OCF Ratio | 3.78 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.61, with an EV/FCF ratio of 26.98.
| EV / Earnings | -6.39 |
| EV / Sales | 1.29 |
| EV / EBITDA | 5.61 |
| EV / EBIT | 110.26 |
| EV / FCF | 26.98 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 1.10.
| Current Ratio | 1.41 |
| Quick Ratio | 0.59 |
| Debt / Equity | 1.10 |
| Debt / EBITDA | 3.52 |
| Debt / FCF | 16.95 |
| Interest Coverage | 0.15 |
Financial Efficiency
Return on equity (ROE) is -20.92% and return on invested capital (ROIC) is 0.45%.
| Return on Equity (ROE) | -20.92% |
| Return on Assets (ROA) | 0.32% |
| Return on Invested Capital (ROIC) | 0.45% |
| Return on Capital Employed (ROCE) | 0.58% |
| Revenue Per Employee | 342,182 |
| Profits Per Employee | -68,819 |
| Employee Count | 5,519 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 3.06 |
Taxes
In the past 12 months, TSX:CURA has paid 137.06 million in taxes.
| Income Tax | 137.06M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.79% in the last 52 weeks. The beta is 0.94, so TSX:CURA's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -79.79% |
| 50-Day Moving Average | 1.20 |
| 200-Day Moving Average | 2.25 |
| Relative Strength Index (RSI) | 48.38 |
| Average Volume (20 Days) | 182,871 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:CURA had revenue of CAD 1.89 billion and -379.81 million in losses. Loss per share was -0.51.
| Revenue | 1.89B |
| Gross Profit | 910.59M |
| Operating Income | 22.02M |
| Pretax Income | -178.35M |
| Net Income | -379.81M |
| EBITDA | 353.54M |
| EBIT | 22.02M |
| Loss Per Share | -0.51 |
Balance Sheet
The company has 175.17 million in cash and 1.53 billion in debt, giving a net cash position of -1.35 billion or -1.78 per share.
| Cash & Cash Equivalents | 175.17M |
| Total Debt | 1.53B |
| Net Cash | -1.35B |
| Net Cash Per Share | -1.78 |
| Equity (Book Value) | 1.38B |
| Book Value Per Share | 1.55 |
| Working Capital | 186.41M |
Cash Flow
In the last 12 months, operating cash flow was 228.58 million and capital expenditures -138.58 million, giving a free cash flow of 90.00 million.
| Operating Cash Flow | 228.58M |
| Capital Expenditures | -138.58M |
| Free Cash Flow | 90.00M |
| FCF Per Share | 0.12 |
Margins
Gross margin is 48.22%, with operating and profit margins of 1.17% and -17.37%.
| Gross Margin | 48.22% |
| Operating Margin | 1.17% |
| Pretax Margin | -9.44% |
| Profit Margin | -17.37% |
| EBITDA Margin | 18.72% |
| EBIT Margin | 1.17% |
| FCF Margin | 4.77% |
Dividends & Yields
TSX:CURA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.97% |
| Shareholder Yield | n/a |
| Earnings Yield | -43.98% |
| FCF Yield | 10.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSX:CURA has an Altman Z-Score of 0.52 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.52 |
| Piotroski F-Score | 6 |